Format

Send to

Choose Destination
Cancer Discov. 2019 Mar;9(3):312. doi: 10.1158/2159-8290.CD-NB2019-009. Epub 2019 Jan 30.

Experts Question Recent Pharma Acquisitions.

[No authors listed]

Abstract

Bristol-Myers Squibb recently purchased Celgene, and Eli Lilly bought Loxo Oncology. These acquisitions probably don't indicate a shift in the types of cancer drugs companies plan to develop, but experts doubt that they will prove profitable and expect that higher drug prices will result, at least in the short term.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center